Terug
53
38
Dagbereik
€ 35,26
€ 36,28
52-Weeksbereik
€ 21,38
€ 46,00
Volume
60.957
50D / 200D Gem.
€ 40,14
/
€ 37,52
Vorige Slotkoers
€ 35,71
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 10,1 | 11,2 |
| P/B | 1,2 | 1,4 |
| ROE % | 12,2 | 10,7 |
| Net Margin % | 4,4 | 5,1 |
| Rev Growth 5Y % | 8,4 | 8,3 |
| D/E | 1,0 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,00
€ 0,00 – € 0,00
|
2,2 B | 0 |
| FY2028 |
€ 5,02
€ 4,95 – € 5,08
|
2 B | 1 |
| FY2027 |
€ 4,92
€ 4,60 – € 5,24
|
1,9 B | 2 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 |
Sills Eric
CEO & President
|
grant | 6.048 | — | — |
| Feb 24, 2026 |
Iles Nathan R.
Chief Financial Officer
|
grant | 7.527 | — | — |
| Feb 24, 2026 |
BURKE JAMES J
Chief Operating Officer
|
grant | 579 | — | — |
| Feb 24, 2026 |
Ringwood Victoria T.
CHRO
|
grant | 3.474 | — | — |
| Nov 10, 2025 |
BURKE JAMES J
Chief Operating Officer
|
grant | 1.014 | — | — |
| Oct 29, 2025 |
Nicholas Ray
CIO & VP IT
|
grant | 3.268 | — | — |
| Oct 29, 2025 |
Iles Nathan R.
Chief Financial Officer
|
grant | 8.795 | — | — |
| Oct 29, 2025 |
BURKE JAMES J
Chief Operating Officer
|
grant | 2.011 | — | — |
| Oct 29, 2025 |
Broccole Carmine Joseph
CLO & Secretary
|
grant | 2.513 | — | — |
| Jul 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
buy | 4.000 | — | — |
| Jul 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 19.690 | € 12,82 | — |
| Jul 2, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 15.598 | € 12,54 | € 195.546 |
| Jul 1, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
other | 61.928 | — | — |
| Jun 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
buy | 4.000 | — | — |
| Jun 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 8.000 | € 12,07 | — |
| May 15, 2025 |
Lieberman Pamela Forbes
Director
|
grant | 4.230 | — | — |
| May 15, 2025 |
McDonnell Joseph W.
Director
|
grant | 4.230 | — | — |
| May 15, 2025 |
McClymont Patrick
Director
|
grant | 4.230 | — | — |
| May 15, 2025 |
Puryear Pamela
Director
|
grant | 4.230 | — | — |
| May 15, 2025 |
Capparelli Alejandro C.
Director
|
grant | 4.230 | — | — |
Belangrijkste Punten
Revenue grew 8,37% annually over 5 years — modest growth
Earnings grew 47,37% over the past year
ROE of 12,16% — decent returns on equity
Generating 18,72M in free cash flow
P/E of 10,12 — trading at a low valuation
PEG of 0,22 suggests growth is underpriced
Groei
Revenue Growth (5Y)
8,37%
Revenue (1Y)22,36%
Earnings (1Y)47,37%
FCF Growth (3Y)-59,77%
Kwaliteit
Return on Equity
12,16%
ROIC10,11%
Net Margin4,41%
Op. Margin10,28%
Veiligheid
Debt / Equity
1,00
Current Ratio2,13
Interest Coverage5,60
Waardering
P/E Ratio
10,12
P/B Ratio1,17
EV/EBITDA7,66
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,36% | Revenue Growth (3Y) | 14,83% |
| Earnings Growth (1Y) | 47,37% | Earnings Growth (3Y) | 11,88% |
| Revenue Growth (5Y) | 8,37% | Earnings Growth (5Y) | -3,43% |
| Profitability | |||
| Revenue (TTM) | 1,79B | Net Income (TTM) | 79,03M |
| ROE | 12,16% | ROA | 3,96% |
| Gross Margin | 30,20% | Operating Margin | 10,28% |
| Net Margin | 4,41% | Free Cash Flow (TTM) | 18,72M |
| ROIC | 10,11% | FCF Growth (3Y) | -59,77% |
| Safety | |||
| Debt / Equity | 1,00 | Current Ratio | 2,13 |
| Interest Coverage | 5,60 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 10,12 | P/B Ratio | 1,17 |
| P/S Ratio | 0,45 | PEG Ratio | 0,22 |
| EV/EBITDA | 7,66 | Dividend Yield | 0,03% |
| Market Cap | 799,47M | Enterprise Value | 1,41B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,79B | 1,46B | 1,36B | 1,37B | 1,30B |
| Net Income | 79,03M | 53,63M | 63,14M | 73,04M | 90,89M |
| EPS (Diluted) | 3,52 | 2,41 | 2,85 | 3,30 | 4,02 |
| Gross Profit | 541,01M | 413,32M | 379,53M | 373,24M | 367,93M |
| Operating Income | 184,05M | 139,22M | 141,24M | 137,91M | 140,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,00B | 1,81B | 1,29B | 1,25B | 1,20B |
| Total Liabilities | 1,30B | 1,18B | 642,17M | 633,89M | 585,33M |
| Shareholders' Equity | 683,70M | 615,75M | 635,06M | 610,02M | 601,58M |
| Total Debt | 682,10M | 660,53M | 245,19M | 280,33M | 159,64M |
| Cash & Equivalents | 72,03M | 44,43M | 32,53M | 21,15M | 21,76M |
| Current Assets | 1,05B | 921,92M | 744,22M | 762,44M | 711,21M |
| Current Liabilities | 493,31M | 436,47M | 304,26M | 323,13M | 476,37M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#160 of 618
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#259 of 332
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026